Everhart Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
1,378
-250
| -15% | -$75.7K | 0.05% | 252 |
|
|
2025
Q1 | $539K | Hold |
1,628
| – | – | 0.07% | 192 |
|
|
2024
Q4 | $502K | Sell |
1,628
-25
| -2% | -$7.71K | 0.1% | 190 |
|
|
2024
Q3 | $351K | Buy |
1,653
+250
| +18% | +$53.1K | 0.08% | 239 |
|
|
2024
Q2 | $393K | Buy |
1,403
+25
| +2% | +$7K | 0.1% | 193 |
|
|
2024
Q1 | $368K | Buy |
1,378
+235
| +21% | +$62.8K | 0.11% | 192 |
|
|
2023
Q4 | $264K | Buy |
+1,143
| New | +$264K | 0.09% | 200 |
|